Brochure
25 Jun 2020

Characterization of Biopharmaceuticals (Flyer)

PDF 133 kB
Download

Comprehensive structural and physicochemical characterization of biopharmaceuticals requires the application of a wide range of analytical principles and methods. Therefor PHARMACELSUS GmbH utilizes a broad spectrum of state-of-the-art instrumentation and thereby putting a strong accent on mass spectrometry (e.g. Orbitrap).

Read more Show less
Content provided by our supplier

GBA Group Pharma

  • DE
  • 2015
    On CPHI since
View company profile

Other Content from GBA Group Pharma (3)

  • GBA Group Pharma: Fields of Expertise (Short Overview)

    Brochure GBA Group Pharma: Fields of Expertise (Short Overview)

    GBA Group Pharma supports throughout the entire lifecycle of a drug - from early lead optimization and preclinical stage to clinical phases and market release. GBA Group Pharma is a fully Brexit proof organisation.
  • GMP Release Testing of Biopharmaceuticals (Flyer)

    Brochure GMP Release Testing of Biopharmaceuticals (Flyer)

    GMP release testing of drug substances and drug products is essential to ensure the quality of biopharmaceuticals, i.e. drugs that are based on large molecules, usually of biotechnological origin. Our service range consists of specific sets of analytical tests and assays, addressing product characteristics like identity, purity, protein content and safety.
  • GBA Pharma Company Presentation (Slide Deck)

    Brochure GBA Pharma Company Presentation (Slide Deck)

    GBA Pharma is a service provider for pharmaceutical companies and is supporting research & development as well as services in the commercial stage.
    Our success and opportunities is based on a high qualified staff. The headcount of GBA Pharma represents 200 employees distributed over 5 locations in Europe with +50% academic staff.
    Our portfolio comprises the following service areas:
    o   Contract research in the preclinical arena (in vitro & in vivo)
    o   Pharmaceutical testing under GMP incl. stability study services & QP release services
    o   Bioanalysis under GLP: in vivo toxicology studies and phase-I/II clinical studies
    o   GMP qualification of API and drug manufacturer outside the European Union
    o   Distribution and clinical trial supply management for multicentre trials
    o   Consultancy & regulatory af...